0001104659-23-120749.txt : 20231122
0001104659-23-120749.hdr.sgml : 20231122
20231122161447
ACCESSION NUMBER: 0001104659-23-120749
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231122
DATE AS OF CHANGE: 20231122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruck Claudine
CENTRAL INDEX KEY: 0001733680
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39202
FILM NUMBER: 231433646
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVE, SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017-3552
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annovis Bio, Inc.
CENTRAL INDEX KEY: 0001477845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262540421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
BUSINESS PHONE: 610-727-3913
MAIL ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
FORMER COMPANY:
FORMER CONFORMED NAME: QR Pharma, Inc.
DATE OF NAME CHANGE: 20091202
4/A
1
tm2331305-7_4aseq1.xml
OWNERSHIP DOCUMENT
X0508
4/A
2023-11-20
2023-11-21
0
0001477845
Annovis Bio, Inc.
ANVS
0001733680
Bruck Claudine
C/O ANNOVIS BIO, INC.
1055 WESTLAKES DRIVE, SUITE 300
BERWYN
PA
19312
1
0
0
0
0
Common Stock
2023-11-20
4
J
0
0
0
A
6567
D
This amendment is being filed solely to reverse the previously reported purchase on the original form 4 filed on November 21, 2023 (the "Original Form 4"). Such purchase was rescinded by the registrant and the reporting person on November 22, 2023.
/s/ Henrey Hagopian III, Attorney-in-Fact for Claudine Bruck
2023-11-22